Finance
FDA Grants Rare Hearing to Vanda Pharmaceuticals After 45 Years
Vanda Pharmaceuticals has secured a historic FDA evidentiary hearing for its jet lag disorder treatment, the first in 45 years. The company also recently gained FDA approval for a therapy that significantly reduces nausea and vomiting associated with popular GLP-1 weight-loss drugs.